Cardinal Health Inc.
Income Statement
| Line Item | FY2010 | FY2009 | FY2008 |
|---|---|---|---|
| Revenue | $98.50B | $95.99B | $87.41B |
| Pharmaceutical | $89.17B | — | — |
| Medical | $9.34B | — | — |
| Eliminations | $-5.0M | — | — |
| Cost of Revenue | $94.72B | $92.24B | $83.63B |
| Gross Profit | $3.78B | $3.75B | $3.78B |
| Gross Margin | 3.8% | 3.9% | 4.3% |
| Operating Expenses | |||
| Research & Development | — | — | — |
| SG&A Expense | $2.40B | $2.33B | $2.34B |
| Operating Income | $1.31B | $1.29B | $1.39B |
| Operating Margin | 1.3% | 1.3% | 1.6% |
| Interest Expense | $113.0M | $114.4M | $136.1M |
| Pretax Income | $1.21B | $1.16B | $1.30B |
| Income Tax Expense | $625.0M | $401.6M | $447.9M |
| Net Income | $642.0M | $1.15B | $1.30B |
| Net Margin | 0.7% | 1.2% | 1.5% |
| EPS (Basic) | $1.79 | $3.22 | — |
| EPS (Diluted) | $1.77 | $3.18 | — |
| Shares Outstanding (Basic) | 359.0M | 357.6M | 358.2M |
| Shares Outstanding (Diluted) | 361.0M | 361.5M | 364.0M |
| Dividends Per Share | $0.70 | $0.56 | $0.48 |